Royalty Pharma plc ( RPRX) - Key Metrics

RPRX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q1 ? ? ? ?
2025Q4 ? ? ? ?
2025Q3 $1.41 $0.67 $1.48 $1.48
2025Q2 $1.34 $0.07 $0.99 $0.99
2025Q1 $1.34 $0.56 $1.40 $1.40

RPRX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q1 ? ?
2025Q4 ? ?
2025Q3 33.07% 13.22
2025Q2 308.99% 129.04
2025Q1 40.01% 13.90

RPRX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q1 3.67% ?
2025Q4 4.96% ?
2025Q3 4.61% 0.63%
2025Q2 2.39% 0.60%
2025Q1 4.40% 0.72%

RPRX

List: Challengers

Price: $54.60

52 week price:
33.37
56.07

Dividend Yield: 1.66%

5-year range yield:
1.51%
3.00%

Forward Dividend Yield: 1.71%

Payout Ratio: 56.00%

Payout Ratio Range:
-18.46%
1963.27%

Dividend Per Share: 0.94 USD

Earnings Per Share: 1.90 USD

P/E Ratio: 27.18

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.0 million

Ebitda: -16.0 million

Market Capitalization: 23.6 billion

Average Dividend Frequency: 4

Years Paying Dividends: 7

DGR3: 6.11%

Links: